approved

Приложение 4 на ПЛС от 02.03.2019 г.

Unique identificator:  d47d1c96-f6d6-4b09-952b-710f06d280af

лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-03-07 10:45:29
  • Created by: georgi_sivchev
  • Updated at: 2019-03-07 10:45:29
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Fulvestrant EU/1/03/269/002 Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 886.62 177.32 1063.94 4% 10.00 896.62 179.32 1075.94 16% 25.00 921.62 184.32 1105.94 корекц. Решение НСР-3464/16.05.2014 НСР-3307/24.04.2014; НСР-14906/25.01.2018 09.02.2018 02.03.2018 Неактивен 2765
Fulvestrant EU/1/03/269/002 Faslodex, Solution for injection, 250 mg/5ml, -, Pack: 2 pre-filled syringes + 2 safety needles AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 938.76 187.75 1126.51 4% 10.00 948.76 189.75 1138.51 16% 25.00 973.76 194.75 1168.51 корекц. Решение НСР-3464/16.05.2014 НСР-3307/24.04.2014 08.05.2014 08.05.2014 Неактивен 2765
Fulvestrant EU/1/03/269/002 Faslodex, Solution for injection, 250 mg/5ml, mg, Pack: 2 AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 945.33 189.07 1134.40 4% 10.00 955.33 191.07 1146.40 16% 25.00 980.33 196.07 1176.40 НСР-1037/23.08.2013 09.09.2013 09.09.2013 Неактивен 2765
Fulvestrant EU/1/03/269/001 Faslodex, Solution for injection, 250, mg, Pack: 1 AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 469.40 93.88 563.28 4% 10.00 479.40 95.88 575.28 16% 25.00 504.40 100.88 605.28 Цената се заличава с решение НСР-3636/29.05.2014 ( в сила от 13.06.2014) НСР-79/07.06.2013 02.07.2013 02.07.2013 Заличен 1880
Fulvestrant EU/1/03/269/001 Faslodex, Solution for injection, 250, mg, Pack: 1 AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 685.30 137.06 822.36 4% 10.00 695.30 139.06 834.36 16% 25.00 720.30 144.06 864.36 КЦРР-869/26.06.2012 24.07.2012 24.07.2012 Неактивен 1880
Fulvestrant EU/1/03/269/001 Faslodex, Solution for injection, 250, mg, Pack: 1 AstraZeneca UK Ltd, Обединено Кралство AstraZeneca UK Ltd, UK 697.08 139.42 836.49 6% 15.00 712.08 142.42 854.49 18% 30.00 742.08 148.42 890.49 КЦ-389/07.01.2009 26.01.2009 26.01.2009 Неактивен 1880
factor VIII inhibitor bypassyng activity 20150284 Feiba, Powder and solvent for solution for infusion, 25 U/ml (500 U), -, Pack: 1 vial 500 U powder for solution for infusion+1 vial 20 ml water for injection+1 administration ste Baxalta Innovations GmbH, Австрия Baxter AG, Австрия 632.40 126.48 758.88 4% 10.00 642.40 128.48 770.88 16% 25.00 667.40 133.48 800.88 НСР-13563/25.08.2017 09.09.2017 02.10.2017 Неактивен 15828
factor VIII inhibitor bypassyng activity 20150284 Feiba, Powder and solvent for solution for infusion, 25 U/ml (500 U), -, Pack: 1 vial 500 U powder for solution for infusion+1 vial 20 ml water for injection+1 administration set Baxalta Innovations GmbH, Австрия Baxter AG, Австрия 625.26 125.05 750.31 4% 10.00 635.26 127.05 762.31 16% 25.00 660.26 132.05 792.31 НСР-13563/25.08.2017; НСР-15794/04.06.2018 (предварително изпълнение) 04.06.2018 02.07.2018 Активен 15828
factor VIII inhibitor bypassyng activity 9700043 Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set Baxter AG, Австрия Baxter AG - Austria 625.26 125.05 750.31 4% 10.00 635.26 127.05 762.31 16% 25.00 660.26 132.05 792.31 Промяна на обстоятелства НСР-14657/18.12.2017 НСР-2195/20.12.2013; НСР-14088/06.10.2017; НСР-15691/17.05.2018 01.06.2018 02.06.2018 Активен 2439
factor VIII inhibitor bypassyng activity 9700043 Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set Baxter AG, Австрия Baxter AG - Austria 632.22 126.44 758.66 4% 10.00 642.22 128.44 770.66 16% 25.00 667.22 133.44 800.66 Промяна на обстоятелства НСР-14657/18.12.2017 НСР-2195/20.12.2013; НСР-14088/06.10.2017 21.10.2017 02.02.2018 Неактивен 2439
factor VIII inhibitor bypassyng activity II-16103/ 15.03.2007 Feiba NF, -, 500, IU, Pack: 1 Baxter AG, Австрия Baxter AG - Austria 639.91 127.98 767.89 4% 10.00 649.91 129.98 779.89 16% 25.00 674.91 134.98 809.89 КЦРР-217/27.02.2012 13.03.2012 13.03.2012 Неактивен 2439
factor VIII inhibitor bypassyng activity II-16103/ 15.03.2007 Feiba NF, -, 500, IU, Pack: 1 Baxter AG, Австрия Baxter AG - Austria 694.32 138.86 833.18 6% 15.00 709.32 141.86 851.18 18% 30.00 739.32 147.86 887.18 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 2439
factor VIII inhibitor bypassyng activity II-16103/ 15.03.2007 Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set Baxter AG, Австрия Baxter AG - Austria 632.22 126.44 758.66 4% 10.00 642.22 128.44 770.66 16% 25.00 667.22 133.44 800.66 НСР-2195/20.12.2013; НСР-14088/06.10.2017 21.10.2017 02.11.2017 Неактивен 2439
factor VIII inhibitor bypassyng activity II-16103/ 15.03.2007 Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set Baxter AG, Австрия Baxter AG - Austria 632.40 126.48 758.88 4% 10.00 642.40 128.48 770.88 16% 25.00 667.40 133.48 800.88 НСР-2195/20.12.2013 06.02.2014 06.02.2014 Неактивен 2439
factor VIII inhibitor bypassyng activity II-16103/ 15.03.2007 Feiba NF, Powder and solvent for solution for injection, 500 U, -, Pack: 1 pre-filled syringe + powd.vial + solv.vial 20 ml + adm.set Baxter AG, Австрия Baxter AG - Austria 632.40 126.48 758.88 4% 10.00 642.40 128.48 770.88 16% 25.00 667.40 133.48 800.88 НСР-2195/20.12.2013 06.02.2014 06.02.2014 Неактивен 2439
Felodipine 20060847 Felicipin, Prolonged release tablet, 5, mg, Pack: 30 Актавис EАД, България Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK 5.55 1.11 6.66 7% 0.39 5.94 1.19 7.13 20% 1.11 7.05 1.41 8.46 промяна на обстоятелства КЦPP-579/04.05.2012; НСР-11449/13.01.2017 КЦ-279/14.11.2008; НСР-16036/29.06.2018 11.12.2008 02.08.2018 Заличен 208
Felodipine 20060847 Felicipin, Prolonged release tablet, 5, mg, Pack: 30 Актавис EАД, България Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK 5.55 1.11 6.66 7% 0.39 5.94 1.19 7.13 20% 1.11 7.05 1.41 8.46 промяна на обстоятелства КЦPP-579/04.05.2012; Промяна на обстоятелства НСР-11449/13.01.2017 КЦ-279/14.11.2008 11.12.2008 02.02.2017 Неактивен 208
Felodipine 0057/20,06,2007 Felicipin, Prolonged release tablet, 5, mg, Pack: 30 Актавис EАД, България Klocke Pharma-Service GmbH, Germany, Siegfried Generics Ltd., Malta, Actavis UK Limited, UK 5.55 1.11 6.66 7% 0.39 5.94 1.19 7.13 20% 1.11 7.05 1.41 8.46 промяна на обстоятелства КЦPP-579/04.05.2012 КЦ-279/14.11.2008 11.12.2008 11.12.2008 Неактивен 208
Felodipine 4055/23,01,2009 Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 Ratiopharm GmbH, Германия Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany 8.61 1.72 10.33 7% 0.60 9.21 1.84 11.05 20% 1.72 10.93 2.19 13.12 цената се заличава КЦРР-2931/20.03.2013 КЦРР-1847/12.12.2012 г 08.02.2013 08.02.2013 Заличен 1572
Felodipine 4054/23,01,2009 Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 Ratiopharm GmbH, Германия Merck KGaARatiopharm BV - Холадия; Merckle GmbH - Germany 4.13 0.83 4.96 7% 0.29 4.42 0.88 5.30 20% 0.83 5.25 1.05 6.30 цената се заличава КЦРР-2935/20.03.2013 КЦРР-1847/12.12.2012 г 08.02.2013 08.02.2013 Заличен 1571
Felodipine 4055/23,01,2009 Felodipine-Ratiopharm, Prolonged release tablet, 10, mg, Pack: 30 Ratiopharm GmbH, Германия Ratiopharm BV - Холадия; Merckle GmbH - Germany 9.00 1.80 10.80 7% 0.63 9.63 1.93 11.56 20% 1.80 11.43 2.29 13.72 КЦ-803/07.04.2009 23.04.2009 23.04.2009 Неактивен 1572
Felodipine 4054/23,01,2009 Felodipine-Ratiopharm, Prolonged release tablet, 5, mg, Pack: 30 Ratiopharm GmbH, Германия Ratiopharm BV - Холадия; Merckle GmbH - Germany 4.69 0.94 5.63 7% 0.33 5.02 1.00 6.02 20% 0.94 5.96 1.19 7.15 КЦ-803/07.04.2009 23.04.2009 23.04.2009 Неактивен 1571
Felodipine 20090190 FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 Чайкафарма Висококачествените лекарства АД, България „Чайкафарма Висококачествените Лекарства”АД, бул. ”Г. М. Димитров” № 1, гр. София 1172, България 2.97 0.59 3.56 7% 0.21 3.18 0.64 3.82 20% 0.59 3.77 0.75 4.52 промяна на обстоятелства НСР-11933/06.03.2017; НСР-13121/06.07.2017 КЦ-959/15.06.2009; НСР-16802/20.09.2018 05.10.2018 02.11.2018 Активен 764
Felodipine 20090190 FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 Чайкафарма Висококачествените лекарства АД, България „Чайкафарма Висококачествените Лекарства”АД, бул. ”Г. М. Димитров” № 1, гр. София 1172, България 4.63 0.93 5.56 7% 0.32 4.95 0.99 5.94 20% 0.93 5.88 1.18 7.06 промяна на обстоятелства НСР-11933/06.03.2017; НСР-13121/06.07.2017 КЦ-959/15.06.2009 01.07.2009 02.08.2017 Неактивен 764
Felodipine 20090190 FELODIPINE-TCHAIKAPHARMA, Prolonged release tablet, 5, mg, Pack: 30 Чайкафарма Висококачествените лекарства АД, България "Чайка фарма-висококачествените лекарства" АД, гр. Пловдив, България 4.63 0.93 5.56 7% 0.32 4.95 0.99 5.94 20% 0.93 5.88 1.18 7.06 промяна на обстоятелства НСР-11933/06.03.2017 КЦ-959/15.06.2009 01.07.2009 02.04.2017 Неактивен 764
Showing 4526 to 4551 of 14509 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте